Marc Antoine Aimé | Regen Lab

ICRS Boston’25

par Marc Antoine Aimé | Sep 16, 2025 | Congress

ICRS Congress 2025 | Boston from 11-14 October 2025. ICRS 2025 – 18th World Congress of the International Cartilage Regeneration & Joint Preservation Society The International Cartilage Regeneration & Joint Preservation Society (ICRS) warmly invites you to...

AMWC Dubai 2025

par Marc Antoine Aimé | Sep 11, 2025 | Congress

AMWC Dubai 2025, Booth C-78 Dubai from 1,2,3 October 2025. PRP is more than a trend — it is evidence-based regenerative medicine. We are pleased to announce that Regen Lab will be exhibiting at AMWC Dubai 2025, taking place from 1 to 3 October at the Grand Hyatt...

ESSM-REGENLAB Webinar Series #2

par Marc Antoine Aimé | Juin 30, 2025 | Corporate

The replay of the ESSM Webinar Series 2024 session, hosted in collaboration with RegenLab, is now available to watch. Female regenerative therapies. State of the art. Watch replay  Moderators Giovanni CoronaMD PhDEndocrinology Unit Prof Dr Daniar...

ESSM – Regen Lab Webinar Series #3

par Marc Antoine Aimé | Juin 19, 2025 | Congress

The replay of the ESSM Webinar Series 2025 session, hosted in collaboration with RegenLab, is now available to watch. A 360° Perspective on Platelet-Rich Plasma (PRP) Therapy to explore its role in the management of:• Female Sexual Dysfunction (FSD)• Stress Urinary...

RegenLab USA Opens New R&D and Manufacturing Facility in Jersey City

par Marc Antoine Aimé | Juin 17, 2025 | Corporate

RegenLab USA Opens New R&D and Manufacturing Facility in Jersey City Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to...

« Entrées précédentes

Entrées suivantes »



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

CM-OA

CM-Skin



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



RegenWound

RegenWound is a fully autologous solution prepared from the patient’s own blood, with the objective of providing a standardised and reproducible approach for clinical use.



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.